Invention Application
- Patent Title: DUAL ANTHRAX-PLAGUE VACCINES THAT CAN PROTECT AGAINST TWO TIER-1 BIOTERROR PATHOGENS, BACILLUS ANTHRACIS AND YERSINIA PESTIS
-
Application No.: US16722124Application Date: 2019-12-20
-
Publication No.: US20200147207A1Publication Date: 2020-05-14
- Inventor: Venigalla B. RAO
- Applicant: The Catholic University of America
- Main IPC: A61K39/295
- IPC: A61K39/295 ; A61K39/02 ; C07K19/00 ; A61K39/07 ; A61K39/385 ; C07K14/005 ; C07K14/32 ; C07K14/24

Abstract:
Bivalent immunogenic compositions against anthrax and plague are disclosed herein. One bivalent immunogenic composition comprises a triple fusion protein containing three antigens, F1 and V from Yersinia pestis and PA antigen from Bacillus anthracis fused in-frame and retaining structural and functional integrity of all three antigens. Another bivalent immunogenic composition comprises bacteriophage nanoparticles arrayed with these three antigens on the capsid surface of the bacteriophage nanoparticles. These bivalent immunogenic compositions are able to elicit robust immune response in a subject administered said the bivalent immunogenic compositions and provide protection to the subject against sequential or simultaneous challenge with both anthrax and plague pathogens.
Public/Granted literature
Information query